{"ORPHApacket":[{"ORPHApacketID":"275786","date":"2019-07-19 08:12:05","version":"1.2.11 \/ 4.1.6 [2018-04-12] (orientdb version)","copyright":"Orphanet (c) 2019","ORPHA":"275786","Name":[{"lang":"en","label":"Drug- or toxin-induced pulmonary arterial hypertension"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_275786","DisorderType":[{"Name":[{"lang":"en","label":"Group of phenomes"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_377794"}],"SubClassOfList":[{"Disorder":[{"Name":[{"lang":"en","label":"Pulmonary arterial hypertension"}],"ORPHA":"182090","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_182090"},{"Name":[{"lang":"en","label":"Disease associated with a genetic susceptibility or tested for a biomarker"}],"ORPHA":"231957","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_231957"}]}],"TextSection":[{"Name":[{"lang":"en","label":"Disease definition"}],"Contents":"Drug- or toxin-induced pulmonary arterial hypertension (PAH) is a form of pulmonary arterial hypertension (PAH, see this term) secondary to the exposition to drugs. Drug- or toxin-induced PAH is characterized by elevated pulmonary arterial resistance leading to right heart failure. Drug or toxin induced PAH is progressive and potentially fatal."}],"AverageAgeOfOnsetList":[{"count":"4","AverageAgeOfOnset":[{"Name":[{"lang":"en","label":"Adolescent"}]},{"Name":[{"lang":"en","label":"Adult"}]},{"Name":[{"lang":"en","label":"Childhood"}]},{"Name":[{"lang":"en","label":"Elderly"}]}]}],"TypeOfInheritanceList":[{"count":"1","TypeOfInheritance":[{"Name":[{"lang":"en","label":"Multigenic\/multifactorial"}]}]}],"SynonymList":[{"count":"1","Synonym":[{"lang":"en","label":"Drug- or toxin-induced PAH"}]}]}]}